Marsico Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-192,695
Closed -$44.4M 103
2016
Q3
$44.4M Buy
192,695
+132,519
+220% +$32.4M 1.66% 19
2016
Q2
$13.9M Buy
+60,176
New +$13.9M 0.48% 39
2015
Q4
Sell
-944,586
Closed -$257M 101
2015
Q3
$257M Sell
944,586
-508,731
-35% -$156M 2.67% 15
2015
Q2
$441M Sell
1,453,317
-164,593
-10% -$49.1M 3.9% 6
2015
Q1
$482M Buy
1,617,910
+350,158
+28% +$99.8M 4.06% 6
2014
Q4
$326M Buy
+1,267,752
New +$317M 2.62% 17

Other funds holding AGN

Marsico Capital Management's AGN Position: Q4 2016 in Review

Marsico Capital Management sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 192,695 shares — an estimated $44.4M sold.

Marsico Capital Management first reported a position in AGN in Q4 2014 and held it in 6 quarters. The position peaked at $482M in Q1 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Marsico Capital Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Marsico Capital Management sold 192,695 Allergan plc shares in Q4 2016, an estimated $44.4M.
  • Marsico Capital Management first reported a position in Allergan plc in Q4 2014 and held it in 6 quarters.
  • Marsico Capital Management's Allergan plc position peaked at $482M in Q1 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Marsico Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.